All GLG News Analyses Filed Under: Infectious Disease

The key to success of marketing Rotarix or similar Rotavirus vaccines is in the design of clinical trials and evaluation of criteria and results of past use of these vaccines in developing countries that have a high incidence of rotavirus diarrhea in infants.  Rotavirus vaccine use...

            ReadyMED® is a infusion device used primarily in outpatient settings for administering antiobiotics in the home.  ReadyMED® requires little patient or caregiver training and works by gravity.  No IV poles or pumps...

The news that Cubist's Cubicin has been contaminated with 2-mercaptobenzothiazole (MBT) has caused great concern for patients. It appears that the MBT has leeched out of the Cardinal Health ReadyMED drug pumps that are used for delivering Cubicin. Regardless of who is at fault, everyone involved (Cubist,...

-Glaxo's Rotarix vaccine was approved last week for prevention of rotavirus infection in infants -Merck's product, Rotateq, on the market for 2 years in the US, already has an established pipeline to essentially all pediatric primary care providers -There are small differences between the 2 vaccines,...

This article fails to explain how Lipsovir will prevent breakouts of new lesions.  They say that early use of the ointment in an episode will shorten the duration about 1 1/2 days but where is the evidence that it prevent new episodes?  Also there is a lot of viral resistance to acyclovir,...

This drug in the form of a patch will solve one problem of vaccination for the Pandemic Flu; that is the two-step process. It also may have impact on the autistic concerns associated with immunizations that are administered containing small amounts of mercury.

The article published in the www.pharmalive.com is presenting a very useful information for preventing common illness, such as cold sores. The successful clinical outcome from phase III trial for Lipsovir is a progressive step for Medivir to develop preventative medicine. Particularly,  the combination...

Many patients wish to rid themselves of recurrent cold sores. If this cream really works, there will be a market for it.

This is a promising shift of money into licensing a drug may be a helpful tool to abate the symptoms. Patient education is an essential component in the treatment of this disease. In a clinical research study in 1999, the use of acupuncture, herbal medicine and patient education were the best...

Impressive 7 day antiviral effects Potential for QD naive and BD experienced approaches Potential for coformulations Revised formulation moving into next phase of testing No critical safety issues in volunteers or patients Metabolit may be anti-gout agent